Isepamicin

Drug Profile

Isepamicin

Alternative Names: 1-N-HAPA gentamicin B; D01825; Exacin; HAPA-B; Isepacin; Isepacine; Isepalline; Isepamicin sulfate; Sch-21420

Latest Information Update: 27 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Schering-Plough
  • Class Aminoglycosides; Antibacterials; Small molecules
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Bacterial infections

Most Recent Events

  • 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
  • 30 Nov 1995 Launched for Bacterial infections in Hong Kong (Parenteral)
  • 09 Nov 1995 Launched for Bacterial infections in South Korea (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top